文献
J-GLOBAL ID:202002251016627830
整理番号:20A0201649
分割RNAゲノムを持つ非伝達性MVベクターは造血細胞由来の異なる型のIPSCを確立する【JST・京大機械翻訳】
Non-transmissible MV Vector with Segmented RNA Genome Establishes Different Types of iPSCs from Hematopoietic Cells
著者 (22件):
Hiramoto Takafumi
(Department of Biochemistry, Jichi Medical University, Tochigi 329-0498, Japan)
,
Tahara Maino
(Department of Virology 3, National Institute of Infectious Diseases, Tokyo 208-0011, Japan)
,
Liao Jiyuan
(Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan)
,
Soda Yasushi
(Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan)
,
Miura Yoshie
(Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan)
,
Kurita Ryo
(Central Blood Institute (Blood Service Headquarters), Japanese Red Cross Society, Tokyo 135-8521, Japan)
,
Hamana Hiroshi
(Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan)
,
Inoue Kota
(Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan)
,
Kohara Hiroshi
(Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan)
,
Miyamoto Shohei
(Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan)
,
Hijikata Yasuki
(Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan)
,
Okano Shinji
(Section of Pathology, Department of Morphological Biology, Fukuoka Dental College, Fukuoka 814-0193, Japan)
,
Yamaguchi Yoshiyuki
(Angel Hospital, Fukuoka 812-8582, Japan)
,
Oda Yoshinao
(Department of Anatomic Pathology, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan)
,
Ichiyanagi Kenji
(Laboratory of Genome and Epigenome Dynamics, Department of Applied Molecular Biosciences, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan)
,
Toh Hidehiro
(Division of Epigenetics and Development, Medical Institute of Bioregulation, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan)
,
Sasaki Hiroyuki
(Division of Epigenetics and Development, Medical Institute of Bioregulation, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan)
,
Kishi Hiroyuki
(Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan)
,
Ryo Akihide
(Department of Microbiology, Yokohama City University, Kanagawa 236-0004, Japan)
,
Muraguchi Atsushi
(Department of Immunology, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, Toyama 930-0194, Japan)
,
Takeda Makoto
(Department of Virology 3, National Institute of Infectious Diseases, Tokyo 208-0011, Japan)
,
Tani Kenzaburo
(Project Division of ALA Advanced Medical Research, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan)
資料名:
Molecular Therapy
(Molecular Therapy)
巻:
28
号:
1
ページ:
129-141
発行年:
2020年
JST資料番号:
W1762A
ISSN:
1525-0016
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)